Text Size
70 studies found for:    "Anaplastic oligoastrocytoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Conditions: Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: Temozolomide
2 Recruiting Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Conditions: Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma;   Brain Tumors;   Brain Cancer
Intervention:
3 Recruiting Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Biological: trebananib;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Other: pharmacological study;   Other: laboratory biomarker analysis
4 Recruiting Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Conditions: Brain Cancer;   MALIGNANT GLIOMA;   Glioblastoma;   Anaplastic Astrocytoma (AA);   Anaplastic Oligodendroglioma (AO);   Anaplastic Oligo-astrocytoma (AOA);   Anaplastic Mixed Gliomas;   Malignant Glioma NOS
Intervention: Other: Bevacizumab & stereotactic radiotherapy
5 Completed Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Conditions: Oligoastrocytoma, Mixed;   Anaplastic Oligodendroglioma
Intervention: Drug: Temozolomide
6 Active, not recruiting Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
7 Recruiting Phase I/II Trial of the Safety, Tolerability, and Anti-tumor Efficacy of AXL1717 (Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Anaplastic Ependymoma
Intervention: Drug: AXL1717
8 Recruiting A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Conditions: Glioblastoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Interventions: Biological: Toca 511;   Drug: 5-FC
9 Active, not recruiting Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
Conditions: Astrocytoma;   Oligo-Astrocytoma;   Glioma
Intervention: Biological: GAA/TT-peptide vaccine and poly-ICLC
10 Recruiting Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine(BCNU);   Procedure: Surgery
11 Not yet recruiting Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine;   Procedure: tumor resection surgery
12 Not yet recruiting Re-irradiation of High Grade Gliomas: a Quality of Life Study
Conditions: Anaplastic Astrocytoma;   Glioblastoma Multiforme;   Anaplastic Oligoastrocytoma
Interventions: Other: EORTC QLQ-C30;   Other: EORTC QLQ-BN20;   Other: Hopkins Verbal Learning Test-Revised (HVLT-R);   Other: Stroop color-word test;   Other: Controlled oral word association test (COWA);   Other: Jamar hand dynamometer;   Other: EORTC QLQ- FA13;   Other: Trail Making Test (TMT)
13 Active, not recruiting BIBF 1120 for Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: BIBF 1120
14 Recruiting A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: Temozolomide;   Drug: α-IFN
15 Recruiting Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
16 Completed Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Recurrent Adult Brain Tumor;   Tumors Metastatic to Brain;   Adult Anaplastic Oligoastrocytoma
Interventions: Drug: bafetinib;   Procedure: microdialysis;   Other: pharmacological study;   Other: liquid chromatography;   Other: mass spectrometry;   Other: laboratory biomarker analysis;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Procedure: therapeutic conventional surgery
17 Active, not recruiting A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Conditions: Adult Anaplastic Astrocytoma;   Recurrent Grade III Glioma;   Recurrent Grade IV Glioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Tumor;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Recurrent Adult Brain Tumor;   Adult Anaplastic Oligoastrocytoma;   Recurrent High Grade Glioma
Interventions: Drug: flucytosine;   Other: polymerase chain reaction;   Other: immunohistochemistry staining method;   Biological: gene therapy;   Other: pharmacological study;   Other: 3-Tesla magnetic resonance imaging;   Other: laboratory biomarker analysis;   Procedure: therapeutic conventional surgery;   Biological: E. coli CD-expressing genetically modified neural stem cells
18 Suspended Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
Conditions: Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Tumor;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma
Interventions: Drug: cilengitide;   Other: laboratory biomarker analysis;   Other: pharmacological study
19 Recruiting Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Conditions: High Grade Glioma: Glioblastoma (GBM);   High Grade Glioma: Gliosarcoma;   Anaplastic Astrocytoma (AA);   Anaplastic Oligodendroglioma (AO);   Mixed Anaplastic Oligoastrocytoma (AOA)
Interventions: Drug: Plerixafor;   Drug: Bevacizumab;   Procedure: Surgery
20 Terminated A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
Conditions: Glioma;   Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Temozolomide and O6-Benzylguanine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years